Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Short term Debt (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Short term Debt for 16 consecutive years, with $11.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Short term Debt rose 311.2% to $11.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $11.3 million, a 311.2% increase, with the full-year FY2024 number at $12.1 million, up 162.22% from a year prior.
  • Short term Debt was $11.3 million for Q3 2025 at Xtant Medical Holdings, down from $12.0 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $16.5 million in Q1 2021 to a low of $708000.0 in Q2 2023.
  • A 5-year average of $6.5 million and a median of $4.1 million in 2021 define the central range for Short term Debt.
  • Peak YoY movement for Short term Debt: skyrocketed 1648900.0% in 2021, then plummeted 81.05% in 2023.
  • Xtant Medical Holdings' Short term Debt stood at $3.6 million in 2021, then crashed by 35.55% to $2.3 million in 2022, then soared by 98.11% to $4.6 million in 2023, then skyrocketed by 162.22% to $12.1 million in 2024, then dropped by 6.7% to $11.3 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Short term Debt are $11.3 million (Q3 2025), $12.0 million (Q2 2025), and $11.3 million (Q1 2025).